Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bug/drug resistance. Sometimes less is more.

C E Phelps1

  • 1Public Policy Analysis Program, University of Rochester, NY 14627.

Medical Care
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychopharmacological characterisation of the successive negative contrast effect in rats.

Psychopharmacology·2015
Same author

Children's responses to overt and relational aggression.

Journal of clinical child psychology·2001
Same author

Economic foundations of cost-effectiveness analysis.

Journal of health economics·1997
Same author

Good technologies gone bad: how and why the cost-effectiveness of a medical intervention changes for different populations.

Medical decision making : an international journal of the Society for Medical Decision Making·1997
Same author

The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms.

International journal of technology assessment in health care·1997
Same author

Perspectives in health economics.

Health economics·1995

Antibiotic resistance poses a significant threat, increasing healthcare costs and potentially leading to death. This study estimates the unrecognized costs of antibiotic use in the U.S. could range from $0.1 billion to over $30 billion annually.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Health Economics

Background:

  • Increasing antibiotic use drives the emergence of resistant bacterial strains.
  • Antibiotic resistance leads to higher medical costs, prolonged hospital stays, and mortality.
  • Understanding the rate of resistance increase is crucial for public health policy.

Purpose of the Study:

  • To estimate the unrecognized annual costs associated with antibiotic use in the United States.
  • To perform a sensitivity analysis using available literature data on antibiotic resistance.
  • To highlight the economic burden of antibiotic resistance.

Main Methods:

  • Sensitivity analysis based on existing literature.
  • Estimation of unrecognized costs for 150 million annual antibiotic prescriptions.

Related Experiment Videos

  • Modeling under various potential scenarios for resistance development.

    • Main Results:

    • Unrecognized costs of antibiotic use are estimated to be at least $0.1 billion annually.
    • In worst-case scenarios, these costs could exceed $30 billion per year.
    • Estimates are highly dependent on unknown parameters like resistance rates and inappropriate use.

    Conclusions:

    • The economic impact of antibiotic resistance is substantial and largely unrecognized.
    • Further research is needed on resistance rates, dose-response patterns, and inappropriate antibiotic use.
    • Improved data is essential to accurately assess and address the antibiotic resistance crisis.